| Roxanne Lucas Aquino, MD | |
|
3733 San Dimas St, Bakersfield, CA 93301-1407 | |
| (800) 353-5400 | |
| Not Available |
| Full Name | Roxanne Lucas Aquino |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 3733 San Dimas St, Bakersfield, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437226370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | A84349 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Roxanne Lucas Aquino, MD 3733 San Dimas St, Bakersfield, CA 93301-1407 Ph: (800) 353-5400 | Roxanne Lucas Aquino, MD 3733 San Dimas St, Bakersfield, CA 93301-1407 Ph: (800) 353-5400 |
News Archive
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
ExeGi Pharma, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today that it has been granted a product license by the Health Canada Natural and Non-prescription Health Products Directorate (NNHPD) to sell Visbiome in Canada.
Mount Sinai researchers have found an important clue to a rare but serious aftereffect of COVID-19 in children, known as a multisystem inflammatory syndrome in children or MIS-C.
In September 2009, the Kansas City District Office of the Food and Drug Administration (FDA) submitted a recommendation of approval to the Center for Drug Evaluation and Research for The University of Iowa Pharmaceuticals (UIP) to manufacture and test an aseptically filled, sterile prescription drug product for a commercial client. The drug product contains a new chemical entity and is a sterile solution that is aseptically filled into vials.
In a systematic review of the worldwide published data on "Venous thromboembolism (VTE) in COVID-19 patients", Cihan Ay, Stephan Nopp, and Florian Moik from the Department of Medicine I, Clinical Division of Haematology and Haemostaseology, now for the first time, provide an in-depth analysis on the risk of VTE in patients hospitalized for COVID-19.
› Verified 9 days ago
Marsha Cheng, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2400 Wible Rd Ste 14, Bakersfield, CA 93304 Phone: 661-835-1240 Fax: 661-835-4667 | |
Sarah Dowda, NP Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 8327 Brimhall Rd Ste 704, Bakersfield, CA 93312 Phone: 661-829-7677 Fax: 661-679-6920 | |
Peter Alagona Jr., M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600 | |
Paramvir Singh Rahal, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9802 Stockdale Hwy, Ste 102, Bakersfield, CA 93311 Phone: 661-323-1200 Fax: 661-616-5339 | |
Harieet Singh, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2415 Niles St, Bakersfield, CA 93306 Phone: 661-631-1591 Fax: 661-631-1594 | |
Bruce G Dains, PAC Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2701 Chester Ave, Highgrove Medical Center, Bakersfield, CA 93301 Phone: 661-326-1600 Fax: 661-323-2307 | |
Dr. Oscar W. Rico, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 9001 Stockdale Hwy, 28 Hc, Bakersfield, CA 93311 Phone: 661-654-2395 |